HomeTBPH • NASDAQ
add
Theravance Biopharma Inc
Previous close
$8.76
Day range
$8.65 - $8.88
Year range
$8.13 - $11.71
Market cap
429.92M USD
Avg Volume
343.08K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 14.50M | 39.22% |
Operating expense | 16.74M | -12.72% |
Net income | -11.66M | 47.19% |
Net profit margin | -80.42 | 62.07% |
Earnings per share | -0.09 | 60.79% |
EBITDA | -11.13M | 50.71% |
Effective tax rate | -12.13% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 99.98M | -58.56% |
Total assets | 371.31M | -31.05% |
Total liabilities | 166.44M | -0.92% |
Total equity | 204.87M | — |
Shares outstanding | 48.63M | — |
Price to book | 2.08 | — |
Return on assets | -7.44% | — |
Return on capital | -10.88% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -11.66M | 47.19% |
Cash from operations | -1.02M | 90.89% |
Cash from investing | 17.03M | 139.56% |
Cash from financing | -1.72M | 96.95% |
Net change in cash | 14.29M | 112.93% |
Free cash flow | 2.47M | 147.76% |
About
Founded
2013
Website
Employees
99